Normal view MARC view ISBD view

High-dose dexmedetomidine for sedation in the intensive care unit: an evaluation of clinical efficacy and safety. [electronic resource]

By:

Jones, G Morgan

Contributor(s):

Producer: 20111007Description: 740-7 p. digitalISSN:

1542-6270

Subject(s):

Online resources:

Available from publisher's website

In: The Annals of pharmacotherapy vol. 45

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

6361 LACE versus BEAM conditioning in relapsed and refractory lymphoma transplant: retrospective multicenter analysis of toxicity and efficacy.
by Khattry, Navin
6362 Isolated limb perfusion as a treatment option for rare types of tumours.
by Belgrano, Valerio
6363 Y
by Voegeli, Michèle
6364 Thiotepa, Etoposide, Cyclophosphamide, Cytarabine, and Melphalan (TECAM) Conditioning Regimen for Autologous Stem Cell Transplantation in Lymphoma.
by Grisariu, Sigal
6365 Aldehyde dehydrogenase activity as the basis for the relative insensitivity of murine pluripotent hematopoietic stem cells to oxazaphosphorines.
by Kohn, F R
6366 Mouse myeloma. A model for studies of cell kinetics.
by Bergsagel, D E
6367 In vitro studies of lymphocytes from patients with plasma cell myeloma. II. Characterization by cell surface markers.
by Mellstedt, H
6368 A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapy.
by Ahmann, D L
6369 An assessment of massive-dose chemotherapy of malignant disease.
by Bergsagel, D E
6370 Interferon-alpha for induction and maintenance in multiple myeloma: results of two multicenter randomized trials and summary of other studies.
by Ludwig, H
6371 Administration of high-dose tumor necrosis factor alpha by isolation perfusion of the limbs. Rationale and results.
by Lejeune, F
6372 Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors.
by Ozkaynak, M F
6373 OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myeloma.
by Colombi, M
6374 A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver.
by Alexander, H R
6375 High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
by Cesaro, S
6376 Acidosis plus melphalan induces nitric oxide-mediated tumor regression in an isolated limb perfusion human melanoma xenograft model.
by Kelley, Scott T
6377 Comparative pharmacokinetic study of high-dose etoposide and etoposide phosphate in patients with lymphoid malignancy receiving autologous stem cell transplantation.
by Dorr, R T
6378 Autologous stem-cell transplantation for non-Hodgkin's lymphomas: the role of graft purging and radiotherapy posttransplantation--results of a retrospective analysis on 120 patients autografted in a single institution.
by Fouillard, L
6379 High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas.
by Gururangan, Sridharan
6380 Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myeloma.
by Timm, M M